THE Therapeutic Goods Administration (TGA) has stripped complementary medicine, FatBlaster Max, of its listing on the Australian Register of Therapeutic Goods (ARTG).
The regulator has alleged the product's sponsor, Cat Media Pty Ltd, breached the Therapeutic Goods Act 1989 by promoting it for a therapeutic use for which it was not listed for.
Cat Media has applied to the Administrative Appeals Tribunal to review the TGA's decision to cancel FatBlaster Max's listing on the ARTG.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 May 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 May 22
